St.Shine Optical (1565) Fundamentals 2026 — P/E 13.4x, Revenue Analysis | SniperIQ
St.Shine Optical (1565) is a TW-listed Healthcare company in Medical - Instruments & Supplies with a market capitalization of NT$4.7B, trading at NT$93.70 on the TWO. This SniperIQ fundamentals page covers St.Shine Optical's valuation (P/E 13.4x, P/B 0.7x), profitability (net margin 9.0%), revenue (NT$4.1B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is St.Shine Optical's market cap?
St.Shine Optical (1565) has a market capitalization of approximately NT$4.7B, trading at NT$93.70 on the TWO. Market cap moves with the live share price.
What is St.Shine Optical's P/E ratio?
St.Shine Optical's trailing twelve-month P/E ratio is 13.4x, with a price-to-book (P/B) of 0.7x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is St.Shine Optical?
St.Shine Optical runs a net profit margin of 9.0%, a gross margin of 21.9%, and an operating margin of 11.5%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does St.Shine Optical generate?
St.Shine Optical reported revenue of NT$4.1B for fiscal year 2025, with net income of NT$455M and earnings per share (EPS) of 9.03. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does St.Shine Optical pay a dividend?
St.Shine Optical offers a trailing dividend yield of about 10.1%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is St.Shine Optical financially healthy?
St.Shine Optical carries a debt-to-equity ratio of 0.06x and a current ratio of 3.53x, with a market beta of 0.30. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is St.Shine Optical a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For St.Shine Optical (1565) the key facts are: market cap NT$4.7B, P/E 13.4x, revenue NT$4.1B, 52-week range 92-167.5. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track St.Shine Optical's full fundamentals live
Get St.Shine Optical's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.